Serum Uric Acid Concentrations Can Predict Hypertension: A Longitudinal Population-Based Epidemiological Study

Abstract

An elevated serum uric acid concentration may be associated with hypertension, which is the leading cause of death worldwide. However, whether the elevation is causal or a consequence of hypertension among the Chinese population remains unclear. This study was designed to investigate the longitudinal relationship between the serum uric acid concentrations and hypertension among Chinese individuals. This study included 5105 subjects, initially without hypertension, who were followed up for 9 years. The subjects were divided into four groups based on the serum uric acid quartile. Cox proportional hazard models were used to analyse the risk factors for hypertension development. Over the 9 years, 2259 of the subjects developed hypertension. The overall 9-year cumulative incidence of hypertension was 44.3%, ranging from 36.3% in quartile 1 to 42.4%, 44.1%, and 54.5% in quartiles 2, 3, and 4, respectively (p for trend<0.001). The Cox regression analyses indicated that the serum uric acid concentrations were independently and positively associated with the risk of incident hypertension. This longitudinal study demonstrated that high serum uric acid concentrations increase the risk of hypertension among the Chinese population.

Key words

hypertension - serum uric acid - association

• References

• 1 Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223
• 2 Mittal BV, Singh AK. Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis 2010; 55: 590-598
• 3 Wang J, Zhang L, Wang F, Liu L, Wang H. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens 2014; 27: 1355-1361
• 4 Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977
• 5 Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J Am Med Assoc 2003; 289: 76-79
• 6 Purnima S, El-Aal BG. Serum uric acid as prognostic marker of coronary heart disease (CHD). Clin Investig Arterioscler 2016; 28: 216-224
• 7 Khichar S, Choudhary S, Singh VB, Tater P, Arvinda RV, Ujjawal V. Serum uric acid level as a determinant of the metabolic syndrome: A case control study. Diabetes Metab Syndr 2017; 11: 19-23
• 8 Mahomed FA. On chronic Bright’s disease, and its essential symptoms. Lancet 1879; 113 (2889) 46-47
• 9 Guidelines Subcommittee. 1999 World Health Organization – International society of hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183
• 10 Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults, 2016 (in Chinese). Chin Circ J 2016; 31: 937-950
• 11 Chinese eGFR Investigation Collaboration. Chinese EGFR Investigation. Modification and evaluation of MDRD estimating equation for Chinese patients with chronic kidney disease (in Chinese). Chin J Nephrol 2006; 22: 589-595
• 12 Poudel B, Yadav BK, Kumar A, Jha B, Raut KB. Serum uric acid level in newly diagnosed essential hypertension in a Nepalese population: a hospital based cross sectional study. Asian Pac J Trop Biomed 2014; 4: 59-64
• 13 Yokokawa H, Fukuda H, Suzuki A, Fujibayashi K, Naito T, Uehara Y, Nakayama A, Matsuo H, Sanada H, Jose PA, Miwa Y, Hisaoka T, Isonuma H. Association between serum uric acid levels/hyperuricemia and hypertension among 85,286 japanese workers. J Clin Hypertens (Greenwich) 2016; 18: 53-59
• 14 Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ. A role for uric acid in the progression of renal disease. Am Soc Nephrol 2002; 13: 2888-2897
• 15 Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 2005; 25: 39-42
• 16 Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008; 26: 269-275
• 17 Forman JP, Choi H, Curhan GC. Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med 2009; 169: 155-162
• 18 Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16: 3553-3562
• 19 Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991; 266: 8604-8608
• 20 Price KL, Sautin YY, Long DA, Zhang L, Miyazaki H, Mu W, Endou H, Johnson RJ. Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol 2006; 17: 1791-1795
• 21 Liu-Bryan R. Intracellular innate immunity in gouty arthritis: role of NALP3 inflammasome. Immunol Cell Biol 2010; 88: 20-23
• 22 Chang YH, Lei CC, Lin KC, Chang DM, Hsieh CH, Lee YJ. Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study. Diabetes Metab Res Rev 2016; 32: 557-564
• 23 Kramer CK, von Mühlen D, Jassal SK, Barrett-Connor E. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study. Diabetes Care 2009; 32: 1272-1273
• 24 Wu S, Pan Y, Zhang N, Jun WY, Wang C. Lower serum uric acid level strongly predict short-term poor functional outcome in acute stroke with normoglycaemia: a cohort study in China. BMC Neurol 2017; 17: 21